Robust prediction of glioma prognosis by hypoxia-induced ferroptosis genes: VEGFA-XBP1 co-expression for salvage therapy - Liwei, Zhou; Hanwen, Lu; Wenpeng, Zhao; Weijie, Yu; Sifang, Chen; Bingchang, Zhang; Zhangyu, Li; Xin, Gao; Wenhua, Li; Jianyao, Mao; Yuanyuan, Xie; Guowei, Tan; et al. (Cancer biology & therapy, 2025)
Keywords: Antineoplastic Agents - pharmacology; Antineoplastic Agents - therapeutic use; Biomarkers, Tumor - analysis; Biomarkers, Tumor - antagonists & inhibitors; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Brain Neoplasms - genetics; Brain Neoplasms - mortality; Brain Neoplasms - pathology; Brain Neoplasms - therapy; Female; ferroptosis; Ferroptosis - drug effects; Ferroptosis - genetics; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; glioma; Glioma - genetics; Glioma - mortality; Glioma - pathology; Glioma - therapy; Humans; Hypoxia; immunity; Male; Middle Aged; Nomograms; prognosis; Research Paper; Risk Assessment - methods; Salvage Therapy - methods; Tumor Hypoxia - drug effects; Tumor Hypoxia - genetics; Vascular Endothelial Growth Factor A - analysis; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Vascular Endothelial Growth Factor A - genetics; Vascular Endothelial Growth Factor A - metabolism; X-Box Binding Protein 1 - analysis; X-Box Binding Protein 1 - antagonists & inhibitors; X-Box Binding Protein 1 - genetics; X-Box Binding Protein 1 - metabolism; Hypoxia; glioma; ferroptosis; immunity; prognosis